Provided by Tiger Trade Technology Pte. Ltd.

Ironwood Pharmaceuticals

4.13
+0.29007.55%
Post-market: 4.11-0.0200-0.48%19:56 EDT
Volume:7.11M
Turnover:29.11M
Market Cap:679.85M
PE:6.91
High:4.17
Open:3.79
Low:3.79
Close:3.84
52wk High:5.78
52wk Low:0.6701
Shares:164.61M
Float Shares:127.00M
Volume Ratio:2.88
T/O Rate:5.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5973
EPS(LYR):0.1484
ROE:-574.72%
ROA:33.15%
PB:-3.13
PE(LYR):27.83

Loading ...

Jun 19, 2026

Major Issues Report

Form 8-K - Current report
Jun 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
May 22, 2026

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
Apr 27, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 11, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2026

Major Issues Report

Form 8-K - Current report
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Major Issues Report

Form 8-K - Current report